GDNF Antibody (MM0308-12F9) - Azide and BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-12335
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Block/Neutralize, ELISA, Western Blot
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG2 Clone # MM0308-12F9
Format
Azide and BSA Free
Concentration
LYOPH mg/ml
Product Specifications
Immunogen
Human recombinant GDNF
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2
Scientific Data Images for GDNF Antibody (MM0308-12F9) - Azide and BSA Free
Western Blot: GDNF Antibody (MM0308-12F9)Azide and BSA Free [NBP2-12335]
Western Blot: GDNF Antibody (MM0308-12F9) - Azide and BSA Free [NBP2-12335] - Human placenta tissue lysate with NBP2-12335 mouse anti-human GDNF antibody.Applications for GDNF Antibody (MM0308-12F9) - Azide and BSA Free
Application
Recommended Usage
Western Blot
1:500-1:1000
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein G purified
Reconstitution
Reconstitute with sterilized PBS to a final concentration of 0.5 mg/ml.
Formulation
Lyophilized from a 0.2 um filtered solution in PBS. 0.025 mg size is provided in liquid form, PBS
Format
Azide and BSA Free
Preservative
No Preservative
Concentration
LYOPH mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: GDNF
Long Name
Glial Cell line-derived Growth Factor
Alternate Names
ATF, HFB1-GDNF, HGDNF, HSCR3
Gene Symbol
GDNF
UniProt
Additional GDNF Products
Product Documents for GDNF Antibody (MM0308-12F9) - Azide and BSA Free
Product Specific Notices for GDNF Antibody (MM0308-12F9) - Azide and BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...